Man9‐Mannosidase from Human Kidney is Expressed in COS Cells as a Golgi‐Resident Type II Transmembrane N‐Glycoprotein

Erhard Bieberich, Ernst Bause

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Man9‐mannosidase, an α1,2–specific exo‐enzyme involved in N‐linked oligosaccharide processing, has been cloned recently from a human kidney cDNA library [Bause, E., Bieberich, E., Rolfs, A., Volker, C. & Schmidt, B. (1993) Eur. J. Biochem. 217, 533–540], Transient expression in COS 1 cells of the enzyme resulted in a more than 20–fold increase of a catalytic activity cleaving specifically α1,2–mannosidic linkages in [14C]Man9‐GlcNAc2 or [14C]Man5‐GlcNAc2. Man9‐mannosidase is expressed as a N‐glycoprotein with a molecular mass of 73 kDa. Its enzymic activity is metal ion dependent and inhibited strongly by 1–deoxymannojirimycin (50% at 100 μM). Proteolytic studies with the membrane‐associated form of Man9‐mannosidase support the view that the enzyme is a type II transmembrane protein as predicted from its cDNA sequence. Several lines of evidence suggest that Man9‐mannosidase, as expressed, is N‐glycosylated at one of three potential Asn‐Xaa‐Thr/Ser/Cys acceptor sites. Approximately 50% of the N‐linked oligosaccharide chains are removed by endoglycosidase H treatment, whereas complete deglycosylation of the enzyme is observed, when transfected cells were cultured in the presence of the Golgi mannosidase II inhibitor swainsonine, indicating that the sugar moiety of Man9‐mannosidase is processed partially by Golgi‐resident enzymes. This observation is consistent with the results of indirect immunofluorescence studies, pointing to a localization of the Man9‐mannosidase predominantly in the juxtanuclear Golgi region. This localization clearly differs from that of pig liver Man9‐mannosidase which appears to be located in the endoplasmic reticulum and transient vesicles.

Original languageEnglish (US)
Pages (from-to)644-649
Number of pages6
JournalEuropean Journal of Biochemistry
Volume233
Issue number2
DOIs
StatePublished - Jan 1 1995

Fingerprint

COS Cells
Kidney
Enzymes
Oligosaccharides
Swainsonine
Glycoside Hydrolases
Molecular mass
Indirect Fluorescent Antibody Technique
Gene Library
Sugars
Endoplasmic Reticulum
Liver
Metal ions
Cultured Cells
Catalyst activity
Swine
Complementary DNA
Metals
Ions
Processing

Keywords

  • expression in COS 1 cells
  • human kidney
  • Man‐mannosidase
  • type II transmembrane N‐glycoprotein subcellular location

ASJC Scopus subject areas

  • Biochemistry

Cite this

Man9‐Mannosidase from Human Kidney is Expressed in COS Cells as a Golgi‐Resident Type II Transmembrane N‐Glycoprotein. / Bieberich, Erhard; Bause, Ernst.

In: European Journal of Biochemistry, Vol. 233, No. 2, 01.01.1995, p. 644-649.

Research output: Contribution to journalArticle

@article{e54fadcdf965465bbe44eb2413773991,
title = "Man9‐Mannosidase from Human Kidney is Expressed in COS Cells as a Golgi‐Resident Type II Transmembrane N‐Glycoprotein",
abstract = "Man9‐mannosidase, an α1,2–specific exo‐enzyme involved in N‐linked oligosaccharide processing, has been cloned recently from a human kidney cDNA library [Bause, E., Bieberich, E., Rolfs, A., Volker, C. & Schmidt, B. (1993) Eur. J. Biochem. 217, 533–540], Transient expression in COS 1 cells of the enzyme resulted in a more than 20–fold increase of a catalytic activity cleaving specifically α1,2–mannosidic linkages in [14C]Man9‐GlcNAc2 or [14C]Man5‐GlcNAc2. Man9‐mannosidase is expressed as a N‐glycoprotein with a molecular mass of 73 kDa. Its enzymic activity is metal ion dependent and inhibited strongly by 1–deoxymannojirimycin (50{\%} at 100 μM). Proteolytic studies with the membrane‐associated form of Man9‐mannosidase support the view that the enzyme is a type II transmembrane protein as predicted from its cDNA sequence. Several lines of evidence suggest that Man9‐mannosidase, as expressed, is N‐glycosylated at one of three potential Asn‐Xaa‐Thr/Ser/Cys acceptor sites. Approximately 50{\%} of the N‐linked oligosaccharide chains are removed by endoglycosidase H treatment, whereas complete deglycosylation of the enzyme is observed, when transfected cells were cultured in the presence of the Golgi mannosidase II inhibitor swainsonine, indicating that the sugar moiety of Man9‐mannosidase is processed partially by Golgi‐resident enzymes. This observation is consistent with the results of indirect immunofluorescence studies, pointing to a localization of the Man9‐mannosidase predominantly in the juxtanuclear Golgi region. This localization clearly differs from that of pig liver Man9‐mannosidase which appears to be located in the endoplasmic reticulum and transient vesicles.",
keywords = "expression in COS 1 cells, human kidney, Man‐mannosidase, type II transmembrane N‐glycoprotein subcellular location",
author = "Erhard Bieberich and Ernst Bause",
year = "1995",
month = "1",
day = "1",
doi = "10.1111/j.1432-1033.1995.644_2.x",
language = "English (US)",
volume = "233",
pages = "644--649",
journal = "FEBS Journal",
issn = "1742-464X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Man9‐Mannosidase from Human Kidney is Expressed in COS Cells as a Golgi‐Resident Type II Transmembrane N‐Glycoprotein

AU - Bieberich, Erhard

AU - Bause, Ernst

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Man9‐mannosidase, an α1,2–specific exo‐enzyme involved in N‐linked oligosaccharide processing, has been cloned recently from a human kidney cDNA library [Bause, E., Bieberich, E., Rolfs, A., Volker, C. & Schmidt, B. (1993) Eur. J. Biochem. 217, 533–540], Transient expression in COS 1 cells of the enzyme resulted in a more than 20–fold increase of a catalytic activity cleaving specifically α1,2–mannosidic linkages in [14C]Man9‐GlcNAc2 or [14C]Man5‐GlcNAc2. Man9‐mannosidase is expressed as a N‐glycoprotein with a molecular mass of 73 kDa. Its enzymic activity is metal ion dependent and inhibited strongly by 1–deoxymannojirimycin (50% at 100 μM). Proteolytic studies with the membrane‐associated form of Man9‐mannosidase support the view that the enzyme is a type II transmembrane protein as predicted from its cDNA sequence. Several lines of evidence suggest that Man9‐mannosidase, as expressed, is N‐glycosylated at one of three potential Asn‐Xaa‐Thr/Ser/Cys acceptor sites. Approximately 50% of the N‐linked oligosaccharide chains are removed by endoglycosidase H treatment, whereas complete deglycosylation of the enzyme is observed, when transfected cells were cultured in the presence of the Golgi mannosidase II inhibitor swainsonine, indicating that the sugar moiety of Man9‐mannosidase is processed partially by Golgi‐resident enzymes. This observation is consistent with the results of indirect immunofluorescence studies, pointing to a localization of the Man9‐mannosidase predominantly in the juxtanuclear Golgi region. This localization clearly differs from that of pig liver Man9‐mannosidase which appears to be located in the endoplasmic reticulum and transient vesicles.

AB - Man9‐mannosidase, an α1,2–specific exo‐enzyme involved in N‐linked oligosaccharide processing, has been cloned recently from a human kidney cDNA library [Bause, E., Bieberich, E., Rolfs, A., Volker, C. & Schmidt, B. (1993) Eur. J. Biochem. 217, 533–540], Transient expression in COS 1 cells of the enzyme resulted in a more than 20–fold increase of a catalytic activity cleaving specifically α1,2–mannosidic linkages in [14C]Man9‐GlcNAc2 or [14C]Man5‐GlcNAc2. Man9‐mannosidase is expressed as a N‐glycoprotein with a molecular mass of 73 kDa. Its enzymic activity is metal ion dependent and inhibited strongly by 1–deoxymannojirimycin (50% at 100 μM). Proteolytic studies with the membrane‐associated form of Man9‐mannosidase support the view that the enzyme is a type II transmembrane protein as predicted from its cDNA sequence. Several lines of evidence suggest that Man9‐mannosidase, as expressed, is N‐glycosylated at one of three potential Asn‐Xaa‐Thr/Ser/Cys acceptor sites. Approximately 50% of the N‐linked oligosaccharide chains are removed by endoglycosidase H treatment, whereas complete deglycosylation of the enzyme is observed, when transfected cells were cultured in the presence of the Golgi mannosidase II inhibitor swainsonine, indicating that the sugar moiety of Man9‐mannosidase is processed partially by Golgi‐resident enzymes. This observation is consistent with the results of indirect immunofluorescence studies, pointing to a localization of the Man9‐mannosidase predominantly in the juxtanuclear Golgi region. This localization clearly differs from that of pig liver Man9‐mannosidase which appears to be located in the endoplasmic reticulum and transient vesicles.

KW - expression in COS 1 cells

KW - human kidney

KW - Man‐mannosidase

KW - type II transmembrane N‐glycoprotein subcellular location

UR - http://www.scopus.com/inward/record.url?scp=0028972747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028972747&partnerID=8YFLogxK

U2 - 10.1111/j.1432-1033.1995.644_2.x

DO - 10.1111/j.1432-1033.1995.644_2.x

M3 - Article

C2 - 7588811

AN - SCOPUS:0028972747

VL - 233

SP - 644

EP - 649

JO - FEBS Journal

JF - FEBS Journal

SN - 1742-464X

IS - 2

ER -